BrightSpring Health Services, Inc. (BTSG)
NEUTRALFundamental
67
Preço
$56.63
Capitalização de Mercado
$11.62B
Parte 1 · Quanto vale a empresa
Visão Geral
BrightSpring Health Services, Inc. operates as a home and community-based healthcare services platform in the United States. The company operates through two segments, Pharmacy Solutions and Provider Services. Its platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It also offers infused, injectable, and oral medication services; and patient-centric, highly skilled, and compassionate clinical home health care, as well as rehabilitation services, including physical, speech and occupational therapy and applied behavioral analysis. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
Balanço & Liquidez
Receita
$14.37B
Últimos 12 meses (até 30/06/2026)
Resultado Líquido
$366M
Últimos 12 meses (até 30/06/2026)
Fluxo de Caixa Livre
$395M
Capital Próprio Total
$1.88B
Passivo Total
$4.53B
Rácio de Liquidez
1.59
Cobertura de Juros
2.94
Dívida/EBITDA
5.20
Resultados Por Ação
Receita & Resultado Líquido
Fluxo de Caixa Livre
Decomposição dos Resultados
Demonstração histórica
Margens ao longo do tempo
A dívida ao longo do tempo
Quanto pesa a dívida
Grelha do crescimento
Crescimento — Receitas
Estimativa de Valor Justo
Valor Justo
$71.31
Preço Atual
$56.63
Margem de Segurança
+20.6%
Intervalo de Valor Justo
$56.87 - $85.75
Métodos de Estimativa
Métricas de Avaliação
Rácio P/E
36.05
ROE
10.2%
Rácio P/B
5.75
P/FCF
29.26
Margem Bruta
12.4%
ROIC
8.0%
Radar de Rentabilidade
Value Creation (Economic Moat)
ROIC
8.0%
WACC
13.2%
ROIC − WACC
-5.2 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Critérios de Análise Fundamental
Aprovado (18)
- EPS shows upward trend
- Price CAGR 86.00%
- ROIC 8.0%
- P/FCF 29.26
- Debt/Equity ratio
- Positive Free Cash Flow
- Current Ratio
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- ROE 19.0%
- Revenue Growth 5Y 18.3%
- Analyst Consensus 96% Buy
- Earnings Surprise avg 17.2%
- PEG Ratio 0.68
- Earnings Quality (OCF/NI) 1.38
- Net Margin Trend 2.5% vs 0.6%
- Piotroski F-Score 7/9
Reprovado (8)
- Gross Margin 12.4%
- P/B Ratio 5.75
- Operating Margin 3.1%
- CapEx intensity
- Low reliance on intangibles
- Price below Graham Number
- DCF valuation (Overvalued)
- Share Dilution 9.2%
Indisponível (1)
- Dividend Payout NaN%
Piotroski F-Score
Saúde financeira sólida
Qualidade dos Resultados
Alta qualidade: resultados respaldados por caixa
Diluição de Ações
A emitir novas ações, diluindo a participação
Governação
Equipa Executiva
| Nome | Cargo | Idade |
|---|---|---|
| Mr. Jon B. Rousseau | Chairman, President & CEO | 51 |
| Ms. Jennifer A. Phipps | CFO, Executive VP & Corporate Secretary | 44 |
| Ms. Lisa Nalley | Chief of Staff & Senior VP of Human Resources | 52 |
| Ms. Jennifer Yowler | Senior VP of Sales & Account Management - PharMerica | 48 |
| Mr. Scott Greenwell Pharm.D. | Executive VP & President of PharMerica | - |
| Mr. Charles H. Wardrip | Chief Information Officer | - |
Risco de Auditoria
7
Risco do Conselho
9
Risco de Remuneração
8
Risco dos Direitos dos Acionistas
8
Parte 2 · O preço e o momento de entrar
Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.
Latest News
Recent headlines for BTSG, sourced from Markets Gazette.
- 2/27/2026NEUTRALBrightSpring (BTSG) Earnings Call Transcript
Markets Gazette reports that BrightSpring Health Services, Inc. (BTSG) held its earnings call on February 27, 2026. However, the detailed content of the transcript is not yet publicly available. Without access to specific financial data, future guidance, or management commentary, investors lack concrete elements to assess the company's performance or outlook. The absence of information prevents a clear directional analysis, leaving the stock in a holding pattern. The market will remain in suspense until the details are published, which could then trigger significant movements once key data points are released.
via Markets Gazette